Karen M. West
President of Solesis
Karen West is an experienced executive, specializing in business development, corporate entrepreneurship, operations and strategic planning and is currently the President of Solesis, a division of Fenner. Her energy, passion and entrepreneurial spirit enables strong, high-level leadership, driving the Division’s growth while also contributing to the Global Leadership of Fenner as part of the Fenner Executive Committee.
More About Karen
Karen received a master’s degree in Business Administration from Lehigh University and a Bachelor of Science degree from Jefferson University. Additionally, she holds a certificate of Corporate Entrepreneurship from Lehigh University.
Karen began her career as a textile and process engineer. Now, as an executive, she brings a deep and broad knowledge of operations, people and processes to everything she does, giving her an exceptional talent for executing her vision. Prior to Solesis, she was instrumental in the development of The Secant Group, from its inception in 2002, to what is now the division’s largest operating company. While at Secant, Karen was able to see and capitalize on existing strengths, aligning them within the business to identify growth opportunities and played a major role in operations, manufacturing, R &D, sales, marketing, and corporate quality management. Karen brings this same insight, wisdom and focus to the division as a whole. Working both domestically and internationally, Karen leverages organic and acquisitive growth and profitability for the Solesis companies in the healthcare sector. She communicates her vision clearly, fueling growth, and delivering exceptional value to the Fenner shareholders by overseeing business performance, operations, and strategic growth for the Division’s operating companies, the Secant Group, Charter Medical, and Sanavita.
Christopher B. Edwards
Vice President, Finance
Chris Edwards and his family have resided in the U.S. since 2008, he is a chartered global management accountant (CGMA) qualifying in Liverpool, U.K., and has an M.B.A. from the Manchester Business School, U.K. Chris Edwards is Vice President of Finance for Solesis, a part of the AEP division of Fenner. Chris joined the Solesis team in 2013.
More About Chris
He is an experienced finance professional who is responsible for all divisional finance activities, as well as shared financial services across the broader Fenner AEP group of companies. As Vice President of Finance for Solesis, Chris works alongside the president of Solesis, Karen West, to oversee the development and expansion of Fenner’s Medical Division.
Although high level strategic finance is Chris’s specialty, he brings more than his financial wisdom/acumen to the team. He has a broad view of business, is commercially minded, with a strong grasp of business outside of finance. Chris has a solid underpinning in global finance having worked for Bristol-Myers Squibb, ConvaTec and Inventiv Health in Europe, the Middle East, Africa and US. Chris spent this time building finance teams, setting up shared services models, supporting senior leadership, as well as managing acquisitions and divestitures. All during an especially challenging time to be doing business in those areas of the globe. Chris has a keen understanding of people, products, international issues, along with mergers and acquisitions.
Over the years, Chris has built a reputation as someone who uses a strategic approach to identify problems, see the details, anticipate the risks, and perform the financial analysis needed to drive growth, organic or via acquisitions, to deliver the most value to shareholders. In his leadership role as Division Finance Director, Chris is instrumental in pursuing the division’s business development strategies, including the integration of acquisitions. Chris also focuses on leading and developing the financial leadership teams at Solesis’s operating companies, Secant Group, Charter Medical and SanaVita.
Vice President, Strategic Markets
Rob is a senior executive with over 20 years of leadership experience in various segments of the Healthcare Industry; including General Management, M&A, Pharmaceutical, Medical Device, and International business strategy. Most recently, Rob was with the Lubrizol Corporation where he served as the General Manager for the LifeSciences division. While there, Rob also held executive roles in Business Development, overseeing two separate Medical Device and Pharmaceutical acquistions, and had responsibility over their various Medical Device divisions. Other notable companies Rob has held leadership positions include, Covidien, Kimberly-Clark HealthCare, and Ballard Medical Products.
More About Rob
Rob joined Solesis in September 2018, as Vice President of Strategic Markets, Rob is a strategic thinker with a demonstrated ability to develop and execute global commercial business strategies enhancing shareholder value, improving revenue and profit, driving product innovation, and delivering customer solutions. He is a creative results-oriented leader experienced in building high performance teams to deliver results. As VP, Strategic Markets, Rob will work to identify market strategies for Solesis. Strategies that are customer focused, multi-dimensional, and that deliver innovative products and value to our customers. As a member of the strategic leadership team of Solesis, he will work to drive both organic growth with expanded product and technology offerings as well as inorganic growth through the acquisition of new technologies and companies that complement Solesis’s existing businesses; ultimately securing Solesis’s position as an Industry Leader.
Rob graduated from University of Arizona with a B.S. in Animal Sciences and pursued post graduate studies at the University of the Philippines in Veterinary Medicine. Rob lives in Ohio with his wife and their 3 children. Rob joined Solesis in March of 2018 as consultant and accepted full time position as the Vice President, Strategic Markets in September of 2018.
Vice President, Solesis
President of Secant Group and Santavita Medical
Jeff Robertson serves as Vice President of Solesis and President of the Secant Group and SanaVita Medical. He joined Secant as a vice president in August 2011, during which time he managed the strategic oversight of business development, marketing, client accounts, product development, and operations. Previously, Jeff worked at ARmark Authentication Technologies, LLC, a wholly owned subsidiary of Adhesives Research, Inc. Robertson co-developed ARmark Authentication Technologies in 2005 and served as the director and general manager.
More About Jeff
Previously, Jeff held various positions at Adhesives Research including being the general manager of a global business unit. He began his career in pharmaceutical sales at Bristol-Meyers Squibb and handled opening a new state organization for Bock Pharmaceuticals. Jeff received a bachelor’s degree in Bio-Behavioral Science (pre-med) from Colby College and a Master’s in Business Administration from Kennedy-Western University.
Get in Touch with Us
To learn more about what we do or how we can work together with you, send us an inquiry and we will get back to you as soon as we can!